Otezla

Amgen Inc🇺🇸 United States

FDA Page

Effective Date: Sep 2, 2026
Approval ID: f6b1f516-4972-4d82-bced-113e47b41cc5
Products: 8 registered
Version: 38

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OTEZLA/OTEZLA XR safely and effectively. See full prescribing information for OTEZLA/OTEZLA XR. OTEZLA (apremilast) tablets, for oral use OTEZLA XR (apremilast) extended-release tablets, for oral use Initial U.S. Approval: 2014

Quick Stats

Total Products8

Labelers3

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.